These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 31119614)

  • 41. Cell-mediated immune response in gonococcal infection.
    Landolfo PJ; Marrie TJ; Nelson NA; Ronald AR
    Can J Microbiol; 1981 Jan; 27(1):76-80. PubMed ID: 6111387
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies on gonococcus infection. IV. Pili: their role in attachment of gonococci to tissue culture cells.
    Swanson J
    J Exp Med; 1973 Mar; 137(3):571-89. PubMed ID: 4631989
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acquired and natural immunity to gonococcal infection in chimpanzees.
    Kraus SJ; Brown WJ; Arko RJ
    J Clin Invest; 1975 Jun; 55(6):1349-56. PubMed ID: 805797
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Strategies for mimicking Neisserial saccharide epitopes as vaccines.
    Gulati S; Ngampasutadol J; Yamasaki R; McQuillen DP; Rice PA
    Int Rev Immunol; 2001; 20(2):229-50. PubMed ID: 11878767
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathogenesis of Neisseria gonorrhoeae in the female reproductive tract: neutrophilic host response, sustained infection, and clinical sequelae.
    Stevens JS; Criss AK
    Curr Opin Hematol; 2018 Jan; 25(1):13-21. PubMed ID: 29016383
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The potential impact of vaccination on the prevalence of gonorrhea.
    Craig AP; Gray RT; Edwards JL; Apicella MA; Jennings MP; Wilson DP; Seib KL
    Vaccine; 2015 Aug; 33(36):4520-4525. PubMed ID: 26192351
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Serotyping Neisseria gonorrhoeae].
    Kohl PK; Petzoldt D
    Hautarzt; 1987 Jan; 38(1):4-9. PubMed ID: 2435677
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The status of vaccines to meningococcal and gonococcal disease.
    Gotschlich EC
    Ann Inst Pasteur Microbiol (1985); 1985; 136B(3):341-55. PubMed ID: 2870677
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Limited local and systemic antibody responses to Neisseria gonorrhoeae during uncomplicated genital infections.
    Hedges SR; Mayo MS; Mestecky J; Hook EW; Russell MW
    Infect Immun; 1999 Aug; 67(8):3937-46. PubMed ID: 10417159
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The novel interaction between Neisseria gonorrhoeae TdfJ and human S100A7 allows gonococci to subvert host zinc restriction.
    Maurakis S; Keller K; Maxwell CN; Pereira K; Chazin WJ; Criss AK; Cornelissen CN
    PLoS Pathog; 2019 Aug; 15(8):e1007937. PubMed ID: 31369630
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase and antigenic variation of pili and outer membrane protein II of Neisseria gonorrhoeae.
    Sparling PF; Cannon JG; So M
    J Infect Dis; 1986 Feb; 153(2):196-201. PubMed ID: 2418125
    [No Abstract]   [Full Text] [Related]  

  • 52. Properly folded and functional PorB from
    Zhu W; Tomberg J; Knilans KJ; Anderson JE; McKinnon KP; Sempowski GD; Nicholas RA; Duncan JA
    J Biol Chem; 2018 Jul; 293(28):11218-11229. PubMed ID: 29752412
    [No Abstract]   [Full Text] [Related]  

  • 53. Genital antibody response to a parenteral gonococcal pilus vaccine.
    McChesney D; Tramont EC; Boslego JW; Ciak J; Sadoff J; Brinton CC
    Infect Immun; 1982 Jun; 36(3):1006-12. PubMed ID: 6124502
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Neisseria gonorrhoeae host adaptation and pathogenesis.
    Quillin SJ; Seifert HS
    Nat Rev Microbiol; 2018 Apr; 16(4):226-240. PubMed ID: 29430011
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibody to reduction modifiable protein increases the bacterial burden and the duration of gonococcal infection in a mouse model.
    Gulati S; Mu X; Zheng B; Reed GW; Ram S; Rice PA
    J Infect Dis; 2015 Jul; 212(2):311-5. PubMed ID: 25596304
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of immune responses to gonococcal PorB delivered as outer membrane vesicles, recombinant protein, or Venezuelan equine encephalitis virus replicon particles.
    Zhu W; Thomas CE; Chen CJ; Van Dam CN; Johnston RE; Davis NL; Sparling PF
    Infect Immun; 2005 Nov; 73(11):7558-68. PubMed ID: 16239559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neisseria gonorrhoeae vaccine development: hope on the horizon?
    Edwards JL; Jennings MP; Seib KL
    Curr Opin Infect Dis; 2018 Jun; 31(3):246-250. PubMed ID: 29601324
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multiple gonococcal pilin antigenic variants are produced during experimental human infections.
    Seifert HS; Wright CJ; Jerse AE; Cohen MS; Cannon JG
    J Clin Invest; 1994 Jun; 93(6):2744-9. PubMed ID: 7911129
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mucosal immunity in the genital tract: prospects for vaccines against sexually transmitted diseases--a review.
    Russell MW; Hedges SR; Wu HY; Hook EW; Mestecky J
    Am J Reprod Immunol; 1999 Jul; 42(1):58-63. PubMed ID: 10429768
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The sixth C. L. Oakley lecture. Molecular studies on the pathogenesis of gonorrhoea.
    Heckels JE
    J Med Microbiol; 1984 Dec; 18(3):293-307. PubMed ID: 6209398
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.